In the mandibular lingual aspect comparison of the six-week and 12-week experimental groups, the difference was nearly significant ( p = 0.053). 4.
← all phrases
“nearly significant”
Sighted at
p=0.0579p=0.06
In the literature
The association between NCAM expression and clinical stage was nearly significant ( P = 0.053) (Table 1 ).
The only statistically significant result was in systolic blood pressure in the ITT analysis ( P = 0.036), and this was nearly significant in the complete-case analysis ( P = 0.053).
The main effect of surgical indication was significant (F [1,25] = 4.495, P = 0.044), and a nearly significant interaction was observed between surgery effects on SRBD and surgical indication F (1,25) = 4.140, P = 0.053.
The interaction Session × Procedure × Focus of attention was nearly significant (F(1,48) = 3.95, p = 0.053).
In this particular scenario, we compared FN-AA with FN-IF treatments, and found that IAA levels in needles exhibited a modest yet statistically significant increase of 13% under amino-acid fertigation ( p = 0.021) while ABA increased by 40%, a nearly significant result ( p = 0.053).
Compared to OVX, major changes exhibited in Sham-OVX samples included nearly significant up-expression of Igf1 (FC = 1.76; P = 0.053), and significant down-expression of Bace1 (FC = 0.77; P = 0.033).
There was a nearly significant main effect of genotype on HOMA-IR (F 1, 26 = 4.12, p = 0.053; Figure 7F ) with increased HOMA-IR in WT females relative to KO, and as expected increased HOMA-IR in HFD females relative to LFD (F 1, 26 = 8.83, p = 0.0063).
While the 2279 nm peak showed a nearly significant correlation with proteinuria (ρ = −0.36, p = 0.053), no significant correlations were observed for the other peaks of interest.
In the second regression ( Figure 6B ), the effect of whole brain ALFF on speech factor scores was nearly significant ( β = 0.30, t = 1.98, p = 0.053), consistent with a nearly significant nonparametric permutation test ( p = 0.055), such that higher whole brain ALFF was associated with higher speech factor scores.
Furthermore, there was a nearly significant difference in the daily psoas muscle loss over the entire study period ( p = 0.053), with group 2 showing a rate of 2.56%, while groups 1 and 3 exhibited rates of 1.47% and 1.42%, respectively.
The post-hoc analysis showed the difference occurred between CBCT and TMJQR (p = .022), while nearly significant difference was found between CBCT and PANO (p = .053), and no difference was found between PANO and TMJQR (p = 1.0).
The only cytokine impacted in both sexes was IL-6, which, compared to air group, was higher in NALF of acrolein-exposed males and females and BALF of acrolein-exposed males, and nearly significant in female BALF ( p = 0.053) ( Figure 2A ).
In addition, there was a significant main effect of RO25–6981 [F (1,16) = 107.26, p < 0.001] and a nearly significant effect of AIE [F (1,16) = 4.38, p = 0.053].
On the other hand, similar to the results with inulin supplementation which resulted in significant increases in butyrate, iso-valerate, and iso-butyrate ( p < .004), omega-3 supplementation resulted in significant increases in iso-butyrate and isovalerate ( p < .002) and nearly significant increases in butyrate ( p < .053).
Complications were also reclassified into none to mild and moderate to severe; the univariate analysis yielded a nearly significant result, with a p -value = 0.053.
Non response group showed significantly more problems on the NMDAS 3 subscale (t = 6.771; p = .021) and nearly significant more problems on total NMDAS scale (t = 3.809; p = 0.053).
The use of Cortiva instead of AlloDerm conferred a nearly significant protective effect against any complication [OR = 0.35 (0.12–1.02); P = 0.053].
PO 4 3− differed significantly among watersheds ( p < 0.001) and season ( p = 0.03) and had a nearly significant interaction of watershed and season ( p = 0.053) (Fig. 3 e).
Serum IgA had a strong correlation (Spearman coefficient, rs,>0.5, p < 0.05) with ALS IgA in all cohorts except those receiving 1.0 μg of dmLT, or a single dose of 2.0 μg, which were both nearly significant, p = 0.053, 0.052, respectively.
[ 18 ] observed that 30 days after discharge from hospital, patients exhibited nearly significant differences in DLCO values (<80%), 42.5% in non-severe cases and 75.6% in severe cases (p < 0.053).
Analysis of lever press to drinking latency data revealed a nearly significant interaction between treatment and viral vector ( F (2,24) = 3.34, p = 0.053, two-way RM ANOVA; data not shown) suggesting that, after DCZ injections, DREADD expressing male mice took longer to initiate a drinking bout following an active lever press.
A total of 91% of patients without comorbid disorders were in remission at follow-up compared to 58.3% for patients with comorbidity (Fisher’s exact test, p = 0.12), and the difference in Y-BOCS (Comorbidity: M = 11.45, SD = 7.03, No-Comorbidity: M = 7.74, SD = 4.83) was nearly significant, t (33) = 2.01, p = 0.053.
Animals treated post-exposure with 1000 nL Anc80-NT3 displayed a frequency-dependent increase in ABR PTS (p = 0.010), and a nearly significant increase in DPOAE PTS (p = 0.053).
The CD4 fraction exhibited comparable negative trends, including a notable inverse correlation with the TSG score (ρ = −.35, P = .029) and a nearly significant association with the oncogene score (ρ = −.31, P = .053).